Alliance Pharma (LON:APH) Sets New 52-Week Low at $33.57

Alliance Pharma plc (LON:APH)’s stock price hit a new 52-week low on Tuesday . The company traded as low as GBX 33.57 ($0.42) and last traded at GBX 34 ($0.43), with a volume of 2296679 shares. The stock had previously closed at GBX 34 ($0.43).

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada decreased their price target on shares of Alliance Pharma from GBX 65 ($0.82) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a research note on Wednesday, January 31st.

Alliance Pharma Price Performance

The business’s 50 day moving average is GBX 38.54 and its two-hundred day moving average is GBX 38.48. The company has a debt-to-equity ratio of 45.00, a quick ratio of 1.42 and a current ratio of 1.93. The firm has a market capitalization of £183.74 million, a PE ratio of -3,400.00, a price-to-earnings-growth ratio of 1.04 and a beta of 0.60.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.